# Rayscape

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rayscape

- Industry: Software
- Headquarters: Timisoara, Poland
- Website: www.rayscape.ai
- Total disclosed funding: $1.1M
- Latest round: Seed (Aug 1, 2024)
- Investors on record: 1

## About

Founded in 2020 in Timisoara, Poland, Rayscape is an innovative company that provides AI-driven radiology solutions, focusing on early disease detection, particularly lung cancer. The company recently completed a Seed funding round in August 2024, raising EUR 1 million led by bValue. 

Rayscape offers radiology solutions powered by artificial intelligence, primarily focusing on X-ray and CT imaging for early disease detection, particularly lung cancer. Their flagship products, Rayscape CXR, and Rayscape Lung CT, leverage machine learning and computer vision technologies to provide analyses of medical images, facilitating decision-making for radiologists. These products are designed to integrate into existing workflow systems used by healthcare facilities, thereby helping in lung nodule detection and other critical diagnoses. Rayscape serves a diverse client base, including hospitals, diagnostic imaging centers, and oncology practices, primarily in North America and Europe.

Rayscape generates revenue through a subscription-based model and direct partnerships with healthcare providers. 

Rayscape plans to enhance its product offerings with new AI-driven imaging solutions set for launch in late 2025. The company is also targeting expansion into the Asian market, particularly in Japan and South Korea, by 2026. The recent Seed funding of EUR 1 million will be allocated towards these product developments and market entry strategies, facilitating growth in new geographic regions and enhancing their technological capabilities.

## Funding rounds

- Seed, Aug 1, 2024, $1.1M — bValue

## Investors

- bValue (https://capitalatlas.ai/funds/bvalue) — Seed